GAMBOA-CEDEÑO, ANGÉLICA MARÍA; DÍAZ, MARIÁNGELES; CRISTALDO, NANCY; OTERO, VICTORIA; SCHUTZ, NATALIA; FANTL, DOROTEA; CUGLIARI, SILVANA; ZERGA, MARTA; ROJAS-BILBAO, ERICA; JAUK, FEDERICO; RIVELLO, HERNÁN GARCÍA; NUÑEZ, MYRIAM; RANUNCOLO, STELLA MARIS

Apoptotic regulator BCL-2 blockade as a potential therapy in classical Hodgkin Lymphoma

LIFE SCIENCES; Año: 2021 vol. 268

CHABAY, PAOLA; LENS, DANIELA; HASSAN, ROCIO; RODRÍGUEZ PINILLA, SOCORRO MARÍA; VALVERT GAMBOA, FABIOLA; RIVERA, IRIS; HUAMÁN GARAICOA, FUAD; RANUNCOLO, STELLA MARIS; BARRIONUEVO, CARLOS; MORALES SÁNCHEZ, ABIGAIL; SCHOLL, VANESA; DE MATTEO, ELENA; PRECIADO, MA. VICTORIA; FUENTES-PANANÁ, EZEQUIEL M.

Lymphotropic Viruses EBV, KSHV and HTLV in Latin America: Epidemiology and Associated Malignancies. A Literature-Based Study by the RIAL-CYTED

Cancers; Lugar: Basel; Año: 2020 vol. 12

GAMBOA-CEDEÑO, ANGÉLICA; CASTILLO, MARIÁNGELES; XIAO, WENMING; WALDMANN, THOMAS; RANUNCOLO, STELLA MARIS

Alternative and canonical NF-kB pathways DNA-binding hierarchies networks define Hodgkin Lymphoma and Non-Hodgkin Diffuse Large B-Cell Lymphoma respectively.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; Lugar: Berlin; Año: 2019

STELLA MARIS RANUNCOLO

Liquid biopsy in liquid tumors

Journal of Cancer Therapy; Año: 2017 vol. 8

ERICA ROJAS-BILBAO; MARÍA ELENA KNOTT; ELISA BAL DE KIER JOFFE; MARTA E. ZERGA; MIRYAM NUÑEZ; LYDIA I. PURICELLI; STELLA MARIS RANUNCOLO

Oct2, BCL6, IRF8, OCAB and PU.1 in the assessment of prognosis in Diffuse Large B Cell Lymphoma patients.

Journal of Molecular Biomarkers & Diagnosis; Lugar: Los Angeles, California; Año: 2016 vol. 7 p. 276 - 284

ME KNOTT; JN MINATTA; L ROULET; L PASIK; SM RANUNCOLO; MYRIAM NUÑEZ; LI PURICELLI; MS DE LORENZO

Circulating Fibroblast Growth Factor 21 (Fgf21) as Diagnostic and Prognostic Biomarker in Renal Cancer

Journal of Molecular Biomarkers & Diagnosis; Lugar: Los Ángeles, California; Año: 2016 vol. 8

CHIORAZZI, M.; RUI, L.; YANG, Y; CEREBELLI, M.; TISHBI, N.; MAURER. C.W.; RANUNCOLO, SM.; ZHAO, H.; XU, W; CHAN, WC.; JAFFE, ES.; GAYSCONE, R; CAMPO, E; ROSSENWALD, A.; OTT, G; DELABIE, J; RIMSZA, L.M.; SHAHAM, S; STAUDT, L.M.

Related F-­‐box proteins control cell death in Caenorhabditis elegans and human lymphoma.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA; Lugar: Washington DC, USA; Año: 2013 vol. 110 p. 3943 - 3948

RANUNCOLO, SM; GHOSH, S.; HANOVER, JA.; HART, GW; LEWIS, BA

Evidence of the involvement of O-GlcNAc-modified Human RNA Polymerase II CTD in transcription in vitro and in vivo.

JOURNAL OF BIOLOGICAL CHEMISTRY; Lugar: Bethesda, Maryland; Año: 2012 vol. 287 p. 23549 - 23561

RANUNCOLO, SM; PITTALUGA, S; EVBUOMWAN, MO; JAFFE, ES; LEWIS, BA

Hodgkin lymphoma requires stabilized NIK and constitutive RelB expression for survival

BLOOD, THE JOURNAL OF THE AMERICAN SOCIETY OF HEMATOLOGY - PRINT; Lugar: Washington DC; Año: 2012 vol. 120 p. 3756 - 3763

JUSZCZYNSKI P,; CHEN, L; O´DONNELL, E.; POLO, JM.; RANUNCOLO, SM; DALLA-FAVERA, R; MELNICK, AM; SHIPP, MA

BCL6 modulates tonic BCR signaling in diffuse large B-cell lymphoma by repressing the SYK phosphatase, PTPROt.

BLOOD, THE JOURNAL OF THE AMERICAN SOCIETY OF HEMATOLOGY - PRINT; Año: 2009 vol. 114 p. 5315 - 5321

RANUNCOLO, SM; WANG, L; POLO, JM.; DELL´OSO, T; DIEROV, J; GAYMES, TJ; RASSOOL, F; CARROLL, M; MELNICK, AM

BCL6-mediated attenuation of DNA damage sensing triggers growth arrest and senescence through a p53-dependent pathway ina cell context-dependent manner.

JOURNAL OF BIOLOGICAL CHEMISTRY; Año: 2008 vol. 283 p. 22565 - 22572

RANUNCOLO, SM; POLO, JM; MELNICK AM.

BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells.

BLOOD CELLS MOLECULES AND DISEASES; Año: 2008 vol. 41 p. 95 - 99

PAREKH, S; POLO, JM; SHAKNOVICH, R; JUSZCZYNSKI, P; LEV, P; RANUNCOLO, SM; YIN, Y; KLEIN, U; CATTORETTI, G; DALLA-FAVERA, R; MELNICK, AM; SHIPP, MA

BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.

BLOOD, THE JOURNAL OF THE AMERICAN SOCIETY OF HEMATOLOGY - PRINT; Año: 2007 vol. 110 p. 2067 - 2074

RANUNCOLO, SM; POLO, JM; DIEROV, J; SINGER, M; KUO, T; GREALLY, J.; GREEN, R.; CARROLL, M.; MELNICK AM.

BCL-6 mediates the germinal center b cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR.

NATURE IMMUNOLOGY (PRINT); Año: 2007 vol. 8 p. 705 - 714

DIAMENT, MJ; PELUFFO, GD; STILLITANI, I; CERCHIETTI, L; NAVIGANTE, A; RANUNCOLO, SM; KLEIN, SM

Inhibition of tumor progresion and paraneoplastic syndrome development in a murine lung adenocarcinoma by medroxiprogesterone acetate and indometacine.

CANCER INVESTIGATION; Año: 2006 vol. 24 p. 126 - 131

POLO, JM; DELL´OSO, T; RANUNCOLO, SM; CERCHIETTI, L; BECK, D; DA SILVA, GF; PRIVE, GG; LICHT, JD; MELNICK, AM

Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells

NATURE MEDICINE.; Año: 2004 vol. 10 p. 1329 - 1335

RANUNCOLO, SM; VARELA, M; MORANDI, A; LASTIRI, JM; CHRISTIANSEN, S; BAL DE KIER JOFFE, ED; PALLOTTA, MG; PURICELLI, LI

Prognostic value of Mdm2, p53 and p16 in patients with astrocytomas.

JOURNAL OF NEURO-ONCOLOGY.; Año: 2004 vol. 68 p. 113 - 121

VARELA, M#; RANUNCOLO, SM#; MORANDI, A; LASTIRI, JM; BAL DE KIER JOFFE, ED; PURICELLI, LI; PALLOTTA, MG

EGF-R and PDGF-R, but not bcl-2 overexpression predict overall survival in patients with low-grade astrocytoma.

JOURNAL OF SURGICAL ONCOLOGY; Año: 2004 vol. 86 p. 34 - 40

RANUNCOLO, SM; ARMANASCO, E; CRESTA, C; BAL DE KIER JOFFE, ED; PURICELLI, LI

Plasma MM-9 (92kDa-MMP) is useful in the follow-up and in the asessment of prognosis in breast cancer patients.

INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER.; Año: 2003 vol. 106 p. 745 - 751

RANUNCOLO, SM.; MATOS, E.; LORIA, D.; VILENSKY, M; ROJO, R; BAL DE KIER JOFFE, ED; PURICELLI, LI

Circulating 92-kilodalton matrix metalloproteinase (MMP-9) activity is enhanced in the euglobulin plasma fraction of head and neck squamous cell carcinoma.

CANCER; Año: 2002 vol. 94 p. 1483 - 1491

RANUNCOLO, SM.; LADEDA, V.; SPECTERMAN, S; VARELA, M; LASTIRI, JM; MORANDI, A; MATOS, E; BAL DE KIER JOFFE, ED; PURICELLI, LI; PALLOTTA, MG

CD44 expression in human gliomas

JOURNAL OF SURGICAL ONCOLOGY; Año: 2002 vol. 79 p. 30 - 36

RANUNCOLO, SM; LADEDA, V; GOROSTIDY, S; MORANDI, A; VARELA, M; LASTIRI, JM; LORIA, D; DEL AGUILA, R; BAL DE KIER JOFFE, ED; PALLOTTA, MG; PURICELLI, LI

Expression of CD44s and CD44 splice variants in human melanoma.

ONCOLOGY REPORTS; Año: 2002 vol. 9 p. 51 - 56

URTREGER, AJ; DIAMENT, MJ; RANUNCOLO, SM; VIDAL, MC; PURICELLI, LI; KLEIN, SM; BAL DE KIER JOFFE, ED

New murine cell line derived from a spontaneous lung tumor induces paraneoplastic syndromes.

INTERNATIONAL JOURNAL OF ONCOLOGY; Año: 2001 vol. 18 p. 639 - 647

FARIAS, E; RANUNCOLO, SM; CRESTA, C; SPECTERMAN, S; ARMANASCO, E; VARELA, M; LASTIRI, JM; PALLOTTA, MG; BAL DE KIER JOFFE, ED; PURICELLI, LI

Plasma metalloproteinase activity is enhanced in the euglobulin fraction of breast and lung cancer patients.

INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER.; Año: 2000 vol. 89 p. 389 - 394